SEC Form 4 · accession 0001615774-17-003293
Tonix Pharmaceuticals Holding Corp. · TNXP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles E Mather IV
Director
Period of report
Jun 20, 2017
Accepted (ET)
Jun 21, 2017 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001430306
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $4.18 | Jun 20, 2017 | A | 20,000 | A | Jun 20, 2018 | Jun 20, 2027 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The option was granted pursuant to the Issuer's 2017 Stock Incentive Plan.